• 1
    Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology. 1997; 202: 849854.
  • 2
    Parker SH, Klaus AJ. Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument. Radiographics. 1997; 17: 12331252.
  • 3
    Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radiology. 1990; 176: 741747.
  • 4
    Parker SH, Jobe WE. Large-core breast biopsy offers reliable diagnosis. Diagn Imaging (San Franc). 1990; 12: 9097.
  • 5
    Parker SH, Jobe WE, Dennis MA, et al. US-guided automated large-core breast biopsy. Radiology. 1993; 187: 507511.
  • 6
    Sickles EA, Parker SH. Appropriate role of core breast biopsy in the management of probably benign lesions. Radiology. 1993; 188: 315.
  • 7
    Ioffe OB, Berg WA, Silverberg SG, Kumar D. Mammographic-histopathologic correlation of large-core needle biopsies of the breast. Mod Pathol. 1998; 11: 721727.
  • 8
    Fuhrman GM, Cederbom GJ, Bolton JS, et al. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities. Ann Surg. 1998; 227: 932939.
  • 9
    Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology. 1993; 188: 453455.
  • 10
    Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA Jr. Stereotactic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology. 1994; 193: 9195.
  • 11
    Reynolds HE, Poon CM, Goulet RJ, Lazaridis CL. Biopsy of breast microcalcifications using an 11-gauge directional vacuum-assisted device. AJR Am J Roentgenol. 1998; 171: 611613.
  • 12
    Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA Jr., Finkelstein SI, Shepard MJ. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology. 1999; 210: 799805.
  • 13
    Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol. 1995; 164: 11111113.
  • 14
    Moore MM, Hargett CW III, Hanks JB, et al. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg. 1997; 225: 726731; discussion, 731–733.
  • 15
    Jackman RJ, Burbank F, Parker SH, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997; 204: 485488.
  • 16
    Brem RF, Behrndt VS, Sanow L, Gatewood OM. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol. 1999; 172: 14051407.
  • 17
    Page DL, Jensen RA, Simpson JF. Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat. 1998; 51: 195208.
  • 18
    Andersen JA. Lobular carcinoma in situ of the breast: an approach to rational treatment. Cancer. 1977; 39: 25972602.
  • 19
    Haagensen CD, Bodian C, Haagensen DE. Lobular neoplasia (lobular carcinoma in situ) breast carcinoma: risk and detection. Volume 238. Philadelphia: W.B. Saunders, 1981.
  • 20
    Wheeler JE, Enterline HT, Roseman JM. Lobular carcinoma in situ of the breast: long-term follow-up. Cancer. 1974; 34: 554563.
  • 21
    Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985; 55: 26982708.
  • 22
    Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr., Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003; 361: 125129.
  • 23
    Lakhani SR. In-situ lobular neoplasia: time for an awakening. Lancet. 2003; 361: 96.
  • 24
    Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 2001; 218: 503509.
  • 25
    Burak WE Jr., Owens KE, Tighe MB, et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg. 2000; 135: 700703.
  • 26
    Bassett L, Winchester DP, Caplan RB, et al. Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists. CA Cancer J Clin. 1997; 47: 171190.
  • 27
    Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985; 312: 146151.
  • 28
    Page DL, Anderson TJ, Rogers LN. Diagnostic histopathology of the breast. New York: Churchill Livingston, 1987.
  • 29
    Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978; 2: 225251.
  • 30
    Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003; 16: 120129.
  • 31
    Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999; 173: 291299.
  • 32
    Crisi GM, Mandavilli S, Cronin E, Ricci A Jr. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol. 2003; 27: 325333.
  • 33
    Lechner MC, Jackman RJ, Brem RF, Evans WP, Parker SH, Smid AP. Lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous biopsy with surgical correlation: a multi-institutional study [abstract]. Radiology. 1999; 213P:106.
  • 34
    Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med. 2002; 126: 697701.
  • 35
    Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 2001; 176: 12551259.
  • 36
    Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB. Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol. 1994; 1: 141146.
  • 37
    Yeh IT, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med. 2003; 127: 4954.
  • 38
    Dmytrasz K, Tartter PI, Mizrachy H, Chinitz L, Rosenbaum Smith S, Estabrook A. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J. 2003; 9: 1012.
  • 39
    Pacelli A, Rhodes DJ, Amrami KK. Outcome of atyical lobular hyperplasia and lobular carcinoma in situ diagnosed by core needle biopsy: clinical and surgical follow-up of 30 cases. Am J Clin Pathol. 2001; 116: 591592.
  • 40
    O'Driscoll D, Britton P, Bobrow L, Wishart GC, Sinnatamby R, Warren R. Lobular carcinoma in situ on core biopsy—what is the clinical significance? Clin Radiol. 2001; 56: 216220.
  • 41
    Renshaw AA, Cartagena N, Derhagopian RP, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol. 2002; 117: 797799.
  • 42
    Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology. 2000; 216: 831837.
  • 43
    Bauer VP, Ditkoff BA, Schnabel F, Brenin D, El-Tamer M, Smith S. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J. 2003; 9: 49.
  • 44
    Zhang RR, O'Hea BJ, Brebbia JR, Fisher PR, Tornos C. Atypical lobular hyperplasia or lobular carcinoma in situ on large core needle biopsy of the breast: is surgical excision necessary [abstract]? Am J Clin Pathol. 2001; 116: 610.
  • 45
    Elsheikh TM, Silverman JF. Is follow-up surgical excision indicated when breast core needle biopsies show lobular hyperplasia or lobular carcinoma in situ? A correlative study of 22 patients [abstract]. Lab Invest. 2001; 81: 127.